Education
About Us
Working with TipRanks
Follow Us
Brainsway (IL:BWAY)
:BWAY
BWAY Stock Chart & Stats
Day’s Range― - ―
52-Week Range1,090.00 - 2,359.00
Previous CloseN/A
Volume32.24K
Average Volume (3M)76.90K
Market Cap
835.64M
Enterprise Value185.89M
Total Cash (Recent Filing)71.60M
Total Debt (Recent Filing)$5.57M
Price to Earnings (P/E)56.6
Beta0.39
Next Earnings
Aug 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)10.60
Shares Outstanding37,794,865
10 Day Avg. Volume107,903
30 Day Avg. Volume76,897
Financial Highlights & Ratios
PEG Ratio1.89
Price to Book (P/B)3.87
Price to Sales (P/S)0.00
P/FCF Ratio31.54
Enterprise Value/Market Cap0.22
Enterprise Value/Revenue1.17
Enterprise Value/Gross Profit5.74
Enterprise Value/Ebitda10.42
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Brainsway News
PremiumCompany Announcements
BrainsWay Reports Strong Q1 2025 Financial Results
BWAY FAQ
What was Brainsway ’s price range in the past 12 months?
Brainsway lowest stock price was 1090.00 and its highest was 2359.00 in the past 12 months.
What is Brainsway ’s market cap?
Brainsway ’s market cap is 835.64M.
When is Brainsway ’s upcoming earnings report date?
Brainsway ’s upcoming earnings report date is Aug 06, 2025 which is in 28 days.
How were Brainsway ’s earnings last quarter?
Brainsway released its earnings results on May 13, 2025. The company reported 10.6 earnings per share for the quarter, beating the consensus estimate of N/A by 10.6.
Is Brainsway overvalued?
According to Wall Street analysts Brainsway ’s price is currently Overvalued.
Does Brainsway pay dividends?
Brainsway does not currently pay dividends.
What is Brainsway ’s EPS estimate?
Brainsway ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Brainsway have?
Brainsway has 37,794,865 shares outstanding.
What happened to Brainsway ’s price movement after its last earnings report?
Brainsway reported an EPS of 10.6 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 8.822%.
Which hedge fund is a major shareholder of Brainsway ?
Currently, no hedge funds are holding shares in IL:BWAY
Company Description
Brainsway
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
BWAY Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
BrainsWay's earnings call highlighted strong revenue growth and an increase in system shipments, alongside advancements in clinical trials and positive cash flow. However, these positives were countered by increased operating expenses and ongoing monitoring of geopolitical and tariff risks.Read More>